39 related articles for article (PubMed ID: 26093198)
1. Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant.
Tai SK; Tan OJ; Chow VT; Jin R; Jones JL; Tan PH; Jayasurya A; Bay BH
Am J Pathol; 2003 Nov; 163(5):2009-19. PubMed ID: 14578200
[TBL] [Abstract][Full Text] [Related]
2. Serum metallothioneins in childhood tumours-a potential prognostic marker.
Kruseova J; Hynek D; Adam V; Kizek R; Prusa R; Hrabeta J; Eckschlager T
Int J Mol Sci; 2013 Jun; 14(6):12170-85. PubMed ID: 23743828
[TBL] [Abstract][Full Text] [Related]
3. Prediagnostic Levels of Copper and Zinc and Breast Cancer Risk in the ORDET Cohort.
Pala V; Agnoli C; Cavalleri A; Rinaldi S; Orlandi R; Segrado F; Venturelli E; Vinceti M; Krogh V; Sieri S
Cancer Epidemiol Biomarkers Prev; 2022 Jun; 31(6):1209-1215. PubMed ID: 35255128
[TBL] [Abstract][Full Text] [Related]
4. Serum Levels of Copper and Zinc and Survival in Breast Cancer Patients.
Szwiec M; Marciniak W; Derkacz R; Huzarski T; Gronwald J; Cybulski C; Dębniak T; Jakubowska A; Lener MR; Falco M; Kładny J; Baszuk P; Kotsopoulos J; Narod SA; Lubiński J
Nutrients; 2024 Mar; 16(7):. PubMed ID: 38613033
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor levels in relation to oxidative damage and antioxidant status in patients with breast cancer.
Pande D; Negi R; Khanna S; Khanna R; Khanna HD
J Breast Cancer; 2011 Sep; 14(3):181-4. PubMed ID: 22031798
[TBL] [Abstract][Full Text] [Related]
6. Serum total oxidant and anti-oxidant status in children with cancer.
Yilmaz Y; Dincaslan H; Ozdemir SI; Tuncer GHE; Tanrioveri B; Kutukcu HB; Tacyildiz N; Unal EC
J Cancer Res Ther; 2024 Jan; 20(1):369-374. PubMed ID: 38554348
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of MT Family Isoforms as Potential Biomarker for Predicting Progression and Prognosis in Gastric Cancer.
Tong M; Lu W; Liu H; Wu J; Jiang M; Wang X; Hao J; Fan D
Biomed Res Int; 2019; 2019():2957821. PubMed ID: 31380415
[TBL] [Abstract][Full Text] [Related]
8. The roles of metallothioneins in carcinogenesis.
Si M; Lang J
J Hematol Oncol; 2018 Aug; 11(1):107. PubMed ID: 30139373
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms (rs10636 and rs28366003) in metallothionein 2A increase breast cancer risk in Chinese Han population.
Liu D; Wang M; Tian T; Wang XJ; Kang HF; Jin TB; Zhang SQ; Guan HT; Yang PT; Liu K; Liu XH; Xu P; Zheng Y; Dai ZJ
Aging (Albany NY); 2017 Feb; 9(2):547-555. PubMed ID: 28228606
[TBL] [Abstract][Full Text] [Related]
10. The Features of Copper Metabolism in the Rat Liver during Development.
Zatulovskaia YA; Ilyechova EY; Puchkova LV
PLoS One; 2015; 10(10):e0140797. PubMed ID: 26474410
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein isoform expression by breast cancer cells.
Barnes NL; Ackland ML; Cornish EJ
Int J Biochem Cell Biol; 2000 Aug; 32(8):895-903. PubMed ID: 10940647
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein--a promising tool for cancer diagnostics.
Krizkova S; Fabrik I; Adam V; Hrabeta J; Eckschlager T; Kizek R
Bratisl Lek Listy; 2009; 110(2):93-7. PubMed ID: 19408840
[TBL] [Abstract][Full Text] [Related]
13. Insight to physiology and pathology of zinc(II) ions and their actions in breast and prostate carcinoma.
Gumulec J; Masarik M; Krizkova S; Adam V; Hubalek J; Hrabeta J; Eckschlager T; Stiborova M; Kizek R
Curr Med Chem; 2011; 18(33):5041-51. PubMed ID: 22050752
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein 2A expression and its relation to different clinical stages and grades of breast cancer in Egyptian patients.
Rezk NA; Zidan HE; Riad M; Mansy W; Mohamad SA
Gene; 2015 Oct; 571(1):17-22. PubMed ID: 26093198
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the diagnostic efficiency of serum oxidative stress parameters in patients with breast cancer at various clinical stages.
Feng JF; Lu L; Dai CM; Wang D; Yang YH; Yang YW; Liu YS
Clin Biochem; 2016 Jun; 49(9):692-698. PubMed ID: 26899366
[TBL] [Abstract][Full Text] [Related]
16. Serum and whole blood Zn, Cu and Mn profiles and their relation to redox status in lung cancer patients.
Zabłocka-Słowińska K; Płaczkowska S; Prescha A; Pawełczyk K; Porębska I; Kosacka M; Pawlik-Sobecka L; Grajeta H
J Trace Elem Med Biol; 2018 Jan; 45():78-84. PubMed ID: 29173487
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
